FI951370A - Tiatsolidinin ja oksatsolidinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö - Google Patents

Tiatsolidinin ja oksatsolidinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö Download PDF

Info

Publication number
FI951370A
FI951370A FI951370A FI951370A FI951370A FI 951370 A FI951370 A FI 951370A FI 951370 A FI951370 A FI 951370A FI 951370 A FI951370 A FI 951370A FI 951370 A FI951370 A FI 951370A
Authority
FI
Finland
Prior art keywords
thiazolidine
preparation
medical use
oxazolidine derivatives
oxazolidine
Prior art date
Application number
FI951370A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951370A0 (fi
Inventor
Takashi Fujita
Takao Yoshioka
Hiroaki Yanagisawa
Hiroaki Fujiwara
Hiroyoshi Horikoshi
Minoru Oguchi
Kunio Wada
Koichi Fujimoto
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI951370A0 publication Critical patent/FI951370A0/fi
Publication of FI951370A publication Critical patent/FI951370A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI951370A 1994-03-23 1995-03-23 Tiatsolidinin ja oksatsolidinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö FI951370A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5154194 1994-03-23

Publications (2)

Publication Number Publication Date
FI951370A0 FI951370A0 (fi) 1995-03-23
FI951370A true FI951370A (fi) 1995-09-24

Family

ID=12889893

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951370A FI951370A (fi) 1994-03-23 1995-03-23 Tiatsolidinin ja oksatsolidinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö

Country Status (15)

Country Link
US (2) US5578620A (no)
EP (1) EP0678511A3 (no)
KR (1) KR950032187A (no)
CN (1) CN1065532C (no)
AU (1) AU682435B2 (no)
CA (1) CA2145257A1 (no)
CZ (1) CZ283938B6 (no)
FI (1) FI951370A (no)
HU (1) HUT71231A (no)
ID (1) ID23600A (no)
IL (1) IL113084A (no)
NO (1) NO303782B1 (no)
NZ (1) NZ270793A (no)
TW (1) TW363959B (no)
ZA (1) ZA952383B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925656A (en) * 1995-04-10 1999-07-20 Dr. Reddy's Research Foundation Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
ATE231136T1 (de) * 1996-04-09 2003-02-15 Reddys Lab Ltd Dr Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven eigenschaften, verfahren zu deren herstellung und pharmazeutischen zusammenstellungen, die sie enthalten
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5889032A (en) * 1996-05-06 1999-03-30 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
CZ298812B6 (cs) * 1996-07-01 2008-02-13 Dr. Reddy's Laboratories Limited Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
HU225415B1 (en) * 1996-07-15 2006-11-28 Sankyo Co Medicinal compositions comprising cs-866 and insulin resistance improving agents and their use for the treatment of arteriosclerosis and xanthoma
TW577875B (en) * 1997-01-31 2004-03-01 Shionogi & Co Pyrrolidine derivatives with inhibitory activity for phospholipase A2
US6313113B1 (en) 1997-04-15 2001-11-06 Reddy-Cheminor, Inc. Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
WO1997041119A1 (en) * 1997-05-02 1997-11-06 Dr. Reddy's Research Foundation Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
DE69824756T2 (de) * 1997-12-02 2005-07-14 Dr. Reddy's Laboratories Ltd. Substituierte thiazolidinedione und oxazolidinedione mit antidiabetischen,hypolipidämischen und antihypertensiven eigenschaften
US6436914B1 (en) 1998-06-30 2002-08-20 Bristol-Myers Squibb Company 2-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonists
CZ2003106A3 (cs) 2000-07-13 2003-04-16 Eli Lilly And Company Agonisté adrenergního beta-3 receptoru
US6514991B2 (en) 2000-07-17 2003-02-04 Wyeth Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists
US6465501B2 (en) 2000-07-17 2002-10-15 Wyeth Azolidines as β3 adrenergic receptor agonists
US6498170B2 (en) 2000-07-17 2002-12-24 Wyeth Cyclamine sulfonamides as β-3 adrenergic receptor agonists
US6451814B1 (en) 2000-07-17 2002-09-17 Wyeth Heterocyclic β-3 adrenergic receptor agonists
US6509358B2 (en) 2000-07-17 2003-01-21 Wyeth Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
US6525202B2 (en) 2000-07-17 2003-02-25 Wyeth Cyclic amine phenyl beta-3 adrenergic receptor agonists
US6444685B1 (en) 2000-07-17 2002-09-03 Wyeth N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists
US6506901B2 (en) 2000-07-17 2003-01-14 Wyeth Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine β-3 adrenergic receptor agonists
US6395762B1 (en) 2000-07-17 2002-05-28 American Home Products Corporation Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
US6537994B2 (en) 2000-07-17 2003-03-25 Wyeth Heterocyclic β3 adrenergic receptor agonists
US6458817B1 (en) 2000-07-17 2002-10-01 Wyeth Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists
US6410734B1 (en) * 2000-07-17 2002-06-25 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
DE60120748T2 (de) 2000-11-10 2007-05-16 Eli Lilly And Co., Indianapolis 3-substituierte oxindolderivate als beta-3-agonisten
WO2002094820A1 (en) * 2001-05-23 2002-11-28 Eli Lilly And Company Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
JP2005507872A (ja) 2001-08-14 2005-03-24 イーライ・リリー・アンド・カンパニー 3−置換オキシインドールβ3アゴニスト
DE60215028T2 (de) 2001-08-14 2007-03-15 Eli Lilly And Co., Indianapolis Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes
ES2242890T3 (es) 2001-11-20 2005-11-16 Eli Lilly And Company Agonistas beta 3 de oxindol 3-sustituido.
WO2003044017A1 (en) 2001-11-20 2003-05-30 Eli Lilly And Company Beta 3 adrenergic agonists
US7009060B2 (en) 2002-01-11 2006-03-07 Eli Lilly And Company 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists
WO2006041921A2 (en) * 2004-10-05 2006-04-20 Auspex Pharmaceuticals, Inc. Preparation and uses of rhodanine derivatives
ES2394349B1 (es) 2012-08-29 2013-11-04 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
US5260445A (en) * 1987-09-04 1993-11-09 Beecham Group P.L.C. 2,4-thiazolidinediones
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−2,4−ジオン誘導体とその塩及び製造法
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NO179246C (no) * 1991-11-20 1996-09-04 Sankyo Co Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav
DE69326736T2 (de) * 1992-08-31 2000-06-08 Sankyo Co Oxazolidin-Derivate mit Antidiabetika und Anti-Fettleibigkeit-Eigenschaften, ihre Herstellung und therapeutische Verwendung
JPH072848A (ja) * 1993-04-23 1995-01-06 Sankyo Co Ltd モルホリンおよびチオモルホリン誘導体

Also Published As

Publication number Publication date
CA2145257A1 (en) 1995-09-24
NZ270793A (en) 1996-02-27
IL113084A0 (en) 1995-06-29
CN1065532C (zh) 2001-05-09
NO303782B1 (no) 1998-08-31
CZ283938B6 (cs) 1998-07-15
TW363959B (en) 1999-07-11
ZA952383B (en) 1995-12-14
NO951095D0 (no) 1995-03-22
FI951370A0 (fi) 1995-03-23
EP0678511A3 (en) 1998-06-10
ID23600A (id) 1995-11-30
AU682435B2 (en) 1997-10-02
HU9500849D0 (en) 1995-05-29
NO951095L (no) 1995-09-25
CN1132750A (zh) 1996-10-09
US5688823A (en) 1997-11-18
CZ73995A3 (en) 1995-12-13
US5578620A (en) 1996-11-26
EP0678511A2 (en) 1995-10-25
IL113084A (en) 1999-01-26
HUT71231A (en) 1995-11-28
KR950032187A (ko) 1995-12-20
AU1501695A (en) 1995-10-05

Similar Documents

Publication Publication Date Title
FI951370A (fi) Tiatsolidinin ja oksatsolidinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö
FI955235A (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
FI955051A (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
FI953479A (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
DE10199018I1 (de) Thiazolidindion-Derivate deren Herstellung und Anwendung
BR9509774A (pt) Fralda descartável
DE69525077T2 (de) Wegwerf-windel
DE69529780D1 (de) Wegwerfwindel
FI956273A0 (fi) Optisesti aktiivinen bentsotiepiinijohdannainen, sen valmistus ja käyttö
FI101382B (fi) Dihydroksipropyylisulfoetyyliselluloosia, niiden valmistus ja käyttö
FI955679A (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö
FI961977A0 (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
EE9900135A (et) N-(2-bensotiasolüül)-1-piperidiinetaanamiini derivaadid, nende valmistamine ja kasutamine raviks
FI956251A0 (fi) 1-okso-2-(fenyylisulfonyyliamino)pentyylipiperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI971317A0 (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
FI894323A0 (fi) Antimikrobiaalinen ainekoostumus, menetelmä ja käyttö
FI971990A (fi) Oksatsolyyli- ja tiatsolyyli-imidatso-bentso- ja tienodiatsepiineja ja niiden käyttö lääkkeinä
EE9800153A (et) 5-naftalen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine
NO953002L (no) Anvendelse av eliprodil og enantiomerer derav for fremstilling av medisinske preparater
DE69517491D1 (de) Wegwerfwindel
EE9900560A (et) 5-naftaleen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine
FI945314A0 (fi) Tetrasolijohdannaiset, niiden valmistus ja käytt¦
FI950021A0 (fi) Tienopyrimidiinijohdannaiset, niiden valmistus ja käyttö
FI940541A0 (fi) Lyfttransportanordning foer foerflyttning och tvaettning av en roerelsehindrad patient
EE02980B1 (et) Bensimidasooli derivaadid, nende valmistamine ja kasutamine